Reconstitution as Chemistry: Concentration, Solubility, and pH

Research-use-only context. This article summarizes published third-party scientific literature and laboratory practice. It is not medical advice, not a therapeutic or performance claim, and not a usage guide. US Prime Peptides products are supplied strictly for in vitro laboratory research and are not for human or veterinary use.

This article describes the reconstitution of a lyophilized peptide as a chemistry problem with three variables: the concentration that results from a given mass in a given volume, the solubility that the sequence allows, and the pH at which the solution ends up. It also explains why some sequences need a solvent other than water and why foaming, shear and container surfaces change what is actually in the vial.

Concentration is mass divided by volume

The concentration of a reconstituted peptide is the mass of peptide in the vial divided by the volume of solvent added: c = m / V. A vial labeled 10 mg brought up in 2.0 mL gives 10 mg / 2.0 mL = 5.0 mg/mL, which is the same quantity written as 5,000 µg/mL or 5 µg/µL.

Molar concentration adds the molecular weight. The amount of substance is n = m / M, so 10 mg of a peptide with a formula mass of 1,419.5 g/mol (the value for the pentadecapeptide BPC-157, C62H98N16O22) is 10 / 1,419.5 = 7.04 µmol, and in 2.0 mL that is 3.52 mmol/L, or 3.52 mM. The molar view matters when peptides of different length are compared, since equal masses are not equal numbers of molecules; the unit conventions are set out in milligrams, micrograms and molarity.

One correction belongs in every calculation. The label mass is the mass of lyophilized material, and a lyophilized material is peptide plus counter-ion plus residual water. If the certificate reports a net peptide content of 85%, a 10 mg label mass contains 8.5 mg of peptide, and 2.0 mL of solvent yields 4.25 mg/mL of peptide rather than 5.0 mg/mL. The distinction is explained in net peptide content vs purity.

Solubility is written in the sequence

Whether a peptide dissolves in water at a given concentration is predictable, within limits, from the proportions of charged and hydrophobic residues in its sequence. Reagent-vendor guides and the solubility literature converge on the same rules of thumb.

Thermo Fisher's peptide design guide gives the working thresholds: peptides shorter than five residues are usually soluble in aqueous solution unless made entirely of hydrophobic residues; hydrophilic peptides with more than 25% charged residues and fewer than 25% hydrophobic residues usually dissolve in water-based solutions; sequences with 50% or more hydrophobic residues may be insoluble or only partly soluble in water and are dissolved first in an organic solvent such as dimethyl sulfoxide, dimethylformamide or acetonitrile before dilution; and sequences in which more than 75% of residues are Asp, Glu, His, Lys, Asn, Gln, Arg, Ser, Thr or Tyr can form intermolecular hydrogen bonds and gel in water.

The literature supports the charge rule at the protein scale and the peptide scale. Kramer and colleagues (Biophysical Journal, 2012) measured the solubility of seven proteins with two different precipitants and found that greater negative surface charge correlated strongly with higher solubility, plausibly because acidic residues bind water tightly. Parthasarathi and colleagues (Journal of Chemical Information and Modeling, 2006) examined 78 human-derived oligopeptides and found solubility partly predicted by hydrophobic moment and charge number rather than by conformational parameters, and the authors recommended a high absolute net charge.

pH sets net charge, and net charge sets solubility

The pH of the final solution decides how many of the ionizable groups in the sequence carry a charge, and a peptide is least soluble at its isoelectric point, the pH at which its net charge is zero.

The counting rule is simple: Asp, Glu and the C-terminal carboxyl each contribute −1; Lys, Arg and the N-terminal amine each contribute +1; His contributes +1 only below about pH 6; acetylation or amidation of the termini removes those terminal charges. A sequence that sums to a negative number is acidic and dissolves best above its isoelectric point; one that sums positive is basic and dissolves best below it. Bachem's handling note gives the matching practice: dissolve a basic peptide in a small volume of an acidic solvent and then dilute; dissolve an acidic peptide in a small volume of a basic solvent such as 0.1% aqueous ammonia and then dilute; and for most sequences at 1 mg/mL or below, phosphate-buffered saline at pH 7.0 to 7.4 is "the safest diluent."

The pH that dissolves a peptide is not always the pH that preserves it. Patel and Borchardt (Pharmaceutical Research, 1990) showed asparagine deamidation accelerating through a cyclic imide between pH 5 and 12 with buffer catalysis between pH 7 and 11. Zapadka and colleagues (Journal of the American Chemical Society, 2016) found that GLP-1 aggregation kinetics switch sharply between pH 7.5 and 8.2, driven by the protonation state of the N-terminus. Bachem notes that free thiols oxidize rapidly above pH 7. The target is a pH far enough from the isoelectric point to dissolve the sequence but outside the window where its particular degradation chemistry accelerates. The counter-ion shifts the starting point, since an unbuffered diluent lands wherever the peptide salt takes it; see TFA salt vs acetate salt.

Why some peptides need a different diluent

Four classes of sequence are better served by a solvent other than plain water, and the choice follows from the chemistry above.

Hydrophobic sequences, at 50% or more hydrophobic residues, are dissolved first in a small volume of DMSO, DMF or acetonitrile and then diluted into the aqueous phase, with the organic fraction kept as low as the solubility allows; Bachem cautions that high organic solvent levels are incompatible with cells. Sequences with a free cysteine are dissolved in degassed, mildly acidic buffer, because thiol oxidation to disulfide is rapid above pH 7. Folded or self-associating sequences may do worse in a preserved diluent: Thirumangalathu and colleagues (2006) showed that 0.9% benzyl alcohol accelerated aggregation of a recombinant protein at pH 7.0, with a larger effect at 37 °C than at 25 °C and none at pH 3.5.

The lipidated GLP-1 class is a special case that combines several of these features and dissolves slowly for reasons of self-association rather than simple hydrophobicity; it is examined in why some peptides dissolve badly. The three common diluents and their labels are compared in bacteriostatic water vs sterile water vs reconstitution solution.

Foaming, shear and gentle mixing

Peptides are amphiphilic, so they adsorb at the air-water interface and can unfold there; a foam is an enormous interface, which is why vigorous agitation during reconstitution is a chemistry error rather than a cosmetic one.

Bee, Randolph and Carpenter (Journal of Pharmaceutical Sciences, 2011) reviewed the published cases in which contact surfaces, including the air-water interface and container materials, caused aggregation and particle formation in protein solutions, and noted that nonionic surfactants such as polysorbate reduce adsorption-induced aggregation. Hawe and colleagues (2009) showed oxytocin degradation following the Arrhenius relationship, which is the argument against warming a slow-dissolving vial: heat raises every degradation rate along with the dissolution rate.

The gentle alternative is to let the solvent run down the inside wall of the vial onto the cake rather than striking the cake directly, to swirl rather than shake, and to allow minutes rather than seconds. Brief sonication in a water bath is a common step in vendor guidance for hydrophobic sequences; it adds energy without creating a foam.

Adsorption: where a dilute solution goes missing

A calculated concentration is only correct if all of the peptide stays in solution rather than on the vessel wall, and at low concentration a meaningful fraction can be lost to the surface.

Goebel-Stengel and colleagues (Analytical Biochemistry, 2011) incubated radiolabeled peptides for 48 hours in plain and siliconized glass and plastic tubes. Siliconization reduced recovery rather than improving it, adding 1% bovine serum albumin improved recovery, and lyophilizing peptide together with albumin gave more than 89% recovery for every peptide tested. Eppendorf's Application Note 180 reports that its low-binding polypropylene recovered 80% more fluorescein-labeled albumin at 1 µg/mL than standard polypropylene, and about 90% after 96 hours of incubation.

The loss is proportionally worst at the lowest concentrations, which is exactly where dilution series end. Low-binding vessels, a carrier protein where the assay permits one, and measuring concentration after preparation rather than assuming it are the controls; the mechanism is explored in why peptides stick to plastic.

Documenting the preparation

A reconstitution record exists so that the concentration can be recomputed later from first principles and so that any later HPLC result can be tied to a specific solvent, pH and container.

The entry should list the peptide lot and certificate reference; the label mass and the net peptide content used in the calculation; the diluent, its lot number and its labeled composition; the volume added and the resulting mass and molar concentration; the measured or estimated pH; the mixing method and time to clarity; the container material; the appearance of the solution; and the date and time. A packaged set such as the Reconstitution Kit is useful mainly because every component arrives with a lot reference that can be copied straight into the record.

Compute the concentration both ways, from label mass and from net peptide content, and state which one the experiment used; and when a solution clouds, gels or clears slowly, write it down, because the certificate will not have predicted it.

Frequently Asked Questions

How do you calculate the concentration of a reconstituted peptide?

Divide the peptide mass by the solvent volume: 10 mg in 2.0 mL is 5.0 mg/mL. For molar concentration, divide the mass by the molecular weight to get moles, then divide by volume; 10 mg of a 1,419.5 g/mol peptide in 2.0 mL is 3.52 mM. Correct the label mass by the certificate's net peptide content first, because the lyophilized mass includes counter-ion and water.

Why will a peptide not dissolve in water?

Usually because the sequence is hydrophobic, or because the water's pH is close to the peptide's isoelectric point where net charge is zero. Thermo Fisher's guide puts the hydrophobic threshold at 50% or more hydrophobic residues, which calls for an organic co-solvent first. Bachem's note gives the pH remedy: dilute acid for basic peptides, dilute ammonia for acidic ones, then dilution.

Does pH matter when reconstituting a peptide?

Yes, in two directions. pH sets the net charge and therefore solubility, with the minimum at the isoelectric point. pH also sets the degradation rate: Patel and Borchardt showed asparagine deamidation accelerating above pH 7, Zapadka showed GLP-1 aggregation switching between pH 7.5 and 8.2, and free thiols oxidize above pH 7.

Should a peptide solution be vortexed?

No. Vortexing creates foam, and a foam is a large air-water interface at which amphiphilic peptides adsorb and unfold; Bee and colleagues reviewed the published cases of interface-driven aggregation. Swirling, time, and brief water-bath sonication for hydrophobic sequences add energy without creating that interface.

Citations

1. Thermo Fisher Scientific. Peptide design: solubility and handling guidelines. thermofisher.com
2. Bachem. Peptide handling and storage. Technical note. bachem.com
3. Kramer RM, Shende VR, Motl N, Pace CN, Scholtz JM. Toward a molecular understanding of protein solubility: increased negative surface charge correlates with increased solubility. Biophys J. 2012;102(8):1907-1915. PMID 22768947
4. Parthasarathi L, Devocelle M, Søndergaard C, Baran I, O'Dushlaine CT, Davey NE, Edwards RJ, Moran N, Kenny D, Shields DC. Absolute net charge and the biological activity of oligopeptides. J Chem Inf Model. 2006;46(5):2183-2190. PMID 16995748
5. Patel K, Borchardt RT. Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide. Pharm Res. 1990;7(7):703-711. PMID 2395797
6. Zapadka KL, Becher FJ, Uddin S, Varley PG, Bishop S, Gomes Dos Santos AL, Jackson SE. A pH-induced switch in human glucagon-like peptide-1 aggregation kinetics. J Am Chem Soc. 2016;138(50):16259-16265. PMID 27998088
7. Thirumangalathu R, Krishnan S, Brems DN, Randolph TW, Carpenter JF. Effects of pH, temperature, and sucrose on benzyl alcohol-induced aggregation of recombinant human granulocyte colony stimulating factor. J Pharm Sci. 2006;95(7):1480-1497. PMID 16729274
8. Bee JS, Randolph TW, Carpenter JF, Bishop SM, Dimitrova MN. Effects of surfaces and leachables on the stability of biopharmaceuticals. J Pharm Sci. 2011;100(10):4158-4170. PMID 21523787
9. Hawe A, Poole R, Romeijn S, Kasper P, van der Heijden R, Jiskoot W. Towards heat-stable oxytocin formulations: analysis of degradation kinetics and identification of degradation products. Pharm Res. 2009;26(7):1679-1688. PMID 19343484
10. Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. PMID 21315060
11. Weiß N, Wente W, Müller P. Eppendorf LoBind: evaluation of protein recovery in Eppendorf Protein LoBind tubes and plates. Eppendorf Application Note 180; November 2010. PDF

This article is for laboratory research reference only. US Prime Peptides products are supplied strictly for in vitro research. Not for human consumption.

Compliance Notice: US Prime Peptides products are supplied strictly for laboratory and academic research purposes only. They are not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any disease. All content on this page is educational in nature and does not constitute medical advice or product claims. Researchers are responsible for handling these compounds in accordance with their institution’s safety protocols and applicable laws.